The role of the Australian Adverse Drug Reactions Advisory Committee (ADRAC) in monitoring drug safety
Author:
- 1 December 2002
- journal article
- Published by Elsevier in Toxicology
- Vol. 181-182, 99-102
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Pharmacotherapeutics: what a difference five decades makes!Medical Journal of Australia, 2001
- Clinical features of tiaprofenic acid (surgam) associated cystitis and a study of risk factors for its developmentJournal of Clinical Epidemiology, 2000
- Risk factors for the development of amoxycillin‐clavulanic acid associated jaundiceMedical Journal of Australia, 1995
- Flucloxacillin hepatitis – an Australian epidemicAustralian and New Zealand Journal of Medicine, 1995
- Tiaprofenic acid as a cause of non‐bacterial cystitisMedical Journal of Australia, 1994
- Risk factors for development of flucloxacillin associated jaundice.BMJ, 1993
- Prolonged hepatic cholestasis after flucloxacillin therapyMedical Journal of Australia, 1989
- Urinary incontinence secondary to prazosinMedical Journal of Australia, 1988
- Glucomannan and risk of oesophageal obstruction.BMJ, 1986
- Mianserin: A Possible Cause of Neutropenia and AgranulocytosisMedical Journal of Australia, 1980